# ENZALUTAMIDE
> **ANDA209645** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2022-04-22
## Drug
- **FDA Application Number:** ANDA209645
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ENZALUTAMIDE
- **Generic name:** Enzalutamide
- **Active ingredients:** ENZALUTAMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** APOTEX
- **First approval:** 2022-04-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209645)
---
*AI Analytics · CC0 1.0*